Metatron 4025 Hunter has NLS method for diagnosing gastric and colon cancer
Metatron 4025 Hunter has NLS method for diagnosing gastric and colon cancer
Nonlinear diagnostic methods (NLS) using metatron 4025 Hunter have recently been actively implemented in many medical institutions. The most tangible results were obtained by using the NLS method as a means of idpensary observations. Over the course of its development and progress, the method has become the most important tool for the diagnosis and monitoring of many diseases of the broad digestive organs: it facilitates a rapid and detailed understanding of lesions and their patterns, and helps to evaluate treatment effects. This has been found in our study of a range of diseases, including gastroduodenal ulcers, chronic gastritis, benign and malignant gastric and colon tumors. The specific characteristics and working conditions of Russian therapeutic and clinical institutions have allowed the NLS methodology to be widely used, not only for the diagnosis of the presence of certain symptoms, but also for drug monitoring. Importantly, speed and low cost enable many patients to utilize NLS information. Physicians can now evaluate patients for potential changes that can only be verified through NLS. In particular, such patients include patients with precancerous diseases or mucus disorders in the upper and/or lower part of the digestive tract and patients with tumors that are still latent at a certain stage.
According to data obtained by some medical experts using the device for NLS diagnosis, and based on studies of thousands of cases each year, the frequency of detecting local or diffuse changes, the frequency of chronic atrophic gastritis is typically 30- within 40%. Spectroscopic analysis of different parts of the focal change pattern of the gastric mucosa showed that different symptoms of diseases including intestinal metaplasia and epithelial dysplasia can be frequently detected in them. During the NLS analysis, gastric ulcer symptoms occurred in approximately 5% of cases, gastric polyps in 7%, and colon polyps in 45%. Therefore, the results of the NLS analysis alone (without accounting for other risk factors) indicated that the majority of patients in each age group appeared to be patients with underlying gastric cancer (GC) or colon cancer (CC) requiring active observation. ).
Two very important factors are known to be critical for malignant disease diagnosis: the quality of clinical and diagnostic techniques and the specific pattern of disease progression, which actually determines the dynamics of disease progression. The diagnostic data for gastric and colon cancer may be considered optimal to a certain extent, given the capacity and working conditions of the treatment facility. This means that even if all patients are susceptible to being diagnosed with the disease during the medical observation period (actually 60% of the problems), it is possible that only 40% of patients will have the first stage detected. An analysis of the reasons for the delayed diagnosis of cases shows that such cases can be prevented through improved organization and methodical work.
Therefore, NLS of Metatron 4025 Hunter can be considered as an appropriate method for the diagnosis of gastric and colon cancer. Difficulties in dealing with NLS interpretation are primarily related to the initial phase, and in the long run the frequency of disease detection depends on the physician's enthusiasm for spectral validation of any focal changes in the mucosa.